10/06/2013
Vestibulodynia: synergy between palmitoylethanolamide + Transpolydatin and transcutaneous electrical nerve stimulation
Murina F. Graziottin A. Felice R. Radici G. Tognocchi C.
Vestibulodynia: synergy between palmitoylethanolamide + Transpolydatin and transcutaneous electrical nerve stimulation
Journal of Lower Genital Tract Disease 2013 Apr; 17 (2): 111-6
The study aimed to assess the effect of palmitoylethanolamide + transpolydatin combination in patients with vestibulodynia undergoing transcutaneous electrical nerve stimulation (TENS) therapy and to confirm the effectiveness of TENS also in a domiciliary protocol.
The study is based on the premise that palmitoylethanolamide + transpolydatin combination may contribute to a down-regulation of mast cell hyperactivity, which is believed to be responsible for the proliferation and sprouting of vestibular pain fibers and the associated hyperalgesia and allodynia.
By courtesy of American Society for Colposcopy and Cervical Pathology - File available for personal use only
top
Related links:
Link to PubMed
Keywords:
Transcutaneous Electrical Nerve Stimulation (TENS)
- Palmitoylethanolamide (PEA)
- Transpolydatin
- Vulvar Vestibulitis / Provoked Vestibulodynia
© 2013 - Alessandra Graziottin Foundation
FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).
WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.